PRF1 and neoplasm: PD‐1 blockade by anti‐PD‐1 antibodies restores the function of exhausted T cells, reactivates the cytotoxicity of CD8+ T cells, and releases perforin, granzyme B, and cytokines, which exhibit cytotoxic activity against tumor cells.1, 5